Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports
Author: Lim, S.
Gillis, D.
Smith, W.
Hissaria, P.
Greville, H.
Peh, C.
Citation: Internal Medicine Journal, 2006; 36(4):260-262
Publisher: Blackwell Publishing Asia
Issue Date: 2006
ISSN: 1444-0903
Statement of
S.W. Lim, D. Gillis, W. Smith, P. Hissaria, H. Greville and C.A. Peh
Abstract: Rituximab is a chimeric monoclonal antibody specific for human CD20 that causes selective transient depletion of the CD20+ B-cell subpopulation. We report the first case of systemic lupus erythematosus (SLE) pneumonitis resistant to conventional treatments that responded well to rituximab and review current reports on the use of rituximab in SLE.
Keywords: rituximab; systemic lupus erythematosus; pneumonitis; B-cell depletion; systemic autoimmune disease
RMID: 0020083003
DOI: 10.1111/j.1445-5994.2006.01055.x
Published version:
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.